"[Yale] should really be well equipped to prevent and detect diversion of controlled substances, especially in the ICU," said Kelly Fitzpatrick of Koskoff Koskoff & Bieder, counsel for the plaintiffs.

New patients will immediately be required to have their doses witnessed, but there will be a transition period for those ...

A lawsuit filed Monday contends that Yale New Haven Health System bears some of the blame for drug diversions by a nurse that ...

Patients and family members accuse Yale and YNHH of failing to relieve pain for ICU patients. The lawsuit comes half a year after YNHH settled another drug diversion case.

Sean Falzarano, then 38, of Southbury, pleaded guilty in December 2024 in federal court to tampering with and stealing ...

In the wake of this epidemic, drug developers have been searching tirelessly for non-addictive medicines that can combat pain without triggering the brain’s reward systems that contribute to the risk ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

In addition to these breakouts, the person will likely experience pain and tenderness. Doctors can treat hidradenitis suppurativa with a range medications, including biologics and hormonal therapies.

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associated with opioids. The drug, which works by ...

A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive. NPR's Yuki ...